← Back

Craneware Plc

Craneware plc develops, licenses, and supports computer software for the U.S. healthcare industry. Its products include Trisus Pricing Analyzer and Transparency, Trisus Chargemaster, InSight Medical Necessity, Trisus Claims Informatics, Trisus Supply, InSight Audit, Trisus Decision Support, Trisus Labor Productivity, Trisus Medication Analytic, Trisus Supplies Assistant, Sentrex, Sentinel, Referral Verification System, and Central Pharmacy Distribution. It also offers professional, pharmacy professional, and appeal services, as well as The Academy, Trisus Pricing Integrity Suite, Trisus Business of Pharmacy Suite, Trisus Value-based Margin and Productivity Suite, and Trisus Data Integrity Suite. Incorporated in 1999, the company is headquartered in Edinburgh, United Kingdom.

Price · split & dividend adjusted
News & notes moving CRW.LSE
United KingdomUnited States
Cloud & Digital Infrastructure▼impact 4

Craneware Shares Fall 24% as Cyberattack and 340B Woes Force FY27 Reset

Craneware shares fell roughly 24% after the Edinburgh-based healthcare software group warned that revenue for the year ending June 2027 is now expected to be around $185 million, roughly in line with its annual recurring revenue base. The reset follows a broadly flat 2026 financial year, in which revenue came in at $206 million versus $205.7 million previously, adjusted EBITDA rose 3% to $67.1 million, the adjusted EBITDA margin improved to 33%, and statutory pretax profit rose 7% to $25.8 million. Annual recurring revenue barely moved at $185 million, while net revenue retention dropped to 100% from 107%. Management blamed growing regulatory uncertainty and increasingly complex requirements from pharmaceutical manufacturers in the US 340B drug-pricing market, which slowed the conversion of identified savings opportunities into transaction revenue. A July cyberattack, disclosed after the financial year ended, added a second blow: hackers gained unauthorized access to part of Craneware's data environment and extracted data, and although core operations continued without disruption and specialists confirmed systems are secure, the company is still determining what data was affected and notifying customers and regulators. Craneware finished the year with $54.8 million of cash and $156 million of undrawn borrowing facilities, and said it has adopted a more cautious planning basis for the next three years, including a comprehensive cost review, with FY27 now effectively a transition year.
About megatrends
Cloud & Digital Infrastructure › Vertical SaaS ▼Demand
Cybersecurity & Digital Trust › Cyber Resilience & Ransomware Recovery ▼Technology
CRW.LSE · Regulation · Negative US 340B drug-pricing regulatory uncertainty slowed conversion of savings into transaction revenue, forcing an FY27 reset
CRW.LSE · Technology · Negative July cyberattack breached part of Craneware's data environment and extracted data, adding a second blow
Read original ↗
Yahoo Finance·15dRead more →
Cybersecurity & Digital Trust▼impact 4

Craneware says hackers stole significant volume of customer data

U.K.-based healthcare billing software maker Craneware disclosed that hackers stole a significant volume of customer data from its systems. The company said the attackers appear to have been expelled, but its investigation is ongoing. Craneware's flagship accounting and billing software is used by thousands of clinics, hospitals, and pharmacies across the United States, and the company handles large amounts of medical records and patient data. The breach is the latest in a series of cyberattacks targeting tech companies that supply the U.S. healthcare sector, following incidents at TriZetto, CareCloud, Episource, and Change Healthcare.
About megatrends
Cybersecurity & Digital Trust › Data Security & Cyber Resilience ▼Regulation
Cybersecurity & Digital Trust › Data Security Posture & DLP ▼Regulation
CRW.LSE · Regulation · Negative Craneware disclosed a significant customer data breach, which may lead to regulatory penalties, legal liability, and reputational damage.
Read original ↗
TechCrunch·78dRead more →